
Orexo AB (publ)
ORXOFOTCHealthcare● Active
$2.90
+$0.80(+38.10%)
Market Cap$101866717
P/E Ratio—
52W High$3.23
52W Low$1.08
Orexo AB (publ) (ORXOF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORXOF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $25.93M | $590.00M | $638.80M | $624.30M | $565.00M |
| Cost of Revenue | $81.30M | $72.10M | $88.90M | $102.60M | $78.90M |
| Gross Profit | ($55.36M) | $517.90M | $549.90M | $521.70M | $486.10M |
| Gross Margin %(computed) | -213.46% | 87.78% | 86.08% | 83.57% | 86.04% |
| Operating Expenses | |||||
| R&D Expenses | $232.52M | $340.00M | $303.10M | $318.00M | $272.30M |
| G&A Expenses | $0.00M | $165.30M | $188.00M | $202.30M | $151.50M |
| Total Operating Expenses | $290.67M | $658.20M | $659.40M | $735.90M | $711.00M |
| Operating Income | ($346.03M) | ($140.30M) | ($109.50M) | ($214.20M) | ($224.90M) |
| Operating Margin %(computed) | — | -23.78% | -17.14% | -34.31% | -39.81% |
| Interest Income | $0.00M | $7.30M | $7.80M | $4.00M | $0.00M |
| Interest Expense | $50.17M | $60.00M | $41.20M | $27.80M | $28.20M |
| Income Before Tax | ($401.99M) | ($190.60M) | ($140.30M) | ($170.40M) | ($222.50M) |
| Income Tax Expense | $0.30M | $12.40M | ($12.00M) | $7.20M | $1.00M |
| Net Income | ($129.47M) | ($203.00M) | ($128.30M) | ($177.60M) | ($223.50M) |
| Net Margin %(computed) | -499.23% | -34.41% | -20.08% | -28.45% | -39.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.74 | $-5.89 | $-3.73 | $-5.17 | $-6.51 |
| Wtd Avg Shares | 34.63M | 34.63M | 34.40M | 34.35M | 34.32M |
| EBITDA | ($285.18M) | $13.00M | ($22.00M) | ($73.90M) | ($141.30M) |
| EBITDA Margin %(computed) | — | 2.20% | -3.44% | -11.84% | -25.01% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SEK · M
Explore more Orexo AB (publ) data
About Orexo AB (publ) (ORXOF) Income Statement
Orexo AB (publ) (ORXOF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ORXOF reported revenue of $0.03B, gross profit of ($0.06B) (gross margin -213.46%), and net income of ($0.13B) — a net profit margin of -499.23%.
Frequently asked questions
ORXOF · 4 questionsOrexo AB (publ) (ORXOF) reported revenue of $0.03B for 2025, down 95.6% year-over-year.
ORXOF revenueORXOF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09